Your browser doesn't support javascript.
loading
Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type Colorectal Cancer.
Jiang, Di Maria; Parshad, Shruti; Zhan, Luna; Sim, Hao-Wen; Siu, Lillian L; Liu, Geoffrey; Shapiro, Jeremy D; Price, Timothy J; Jonker, Derek J; Karapetis, Christos S; Strickland, Andrew H; Zhang, Wenjiang; Jeffery, Mark; Tu, Dongsheng; Ng, Siobhan; Sabesan, Sabe; Shannon, Jenny; Townsend, Amanda; O'Callaghan, Chris J; Chen, Eric X.
Afiliación
  • Jiang DM; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON.
  • Parshad S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON.
  • Zhan L; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON.
  • Sim HW; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, and NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Ausutralia.
  • Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON.
  • Liu G; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON.
  • Shapiro JD; Department of Medical Oncology, Cabrini Hospital, Cabrini Monash University, Melbourne, Australia.
  • Price TJ; Department of Hematology and Oncology, Queen Elizabeth Hospital, CALHN, Adelaide, South Australia.
  • Jonker DJ; Ottawa Hospital Research Institute, University of Ottawa, Ottawa ON.
  • Karapetis CS; Flinders Medical Center, Flinders University, Adelaide, South Australia.
  • Strickland AH; Monash Cancer Centre, Monash University, Clayton, Australia.
  • Zhang W; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON.
  • Jeffery M; Canterbury Regional Cancer and Hematology Service Centre, Christchurch Hospital, Christchurch, New Zealand.
  • Tu D; Canadian Cancer Trials Group, Queen's University, Kingston, ON.
  • Ng S; Sir Charles Gairdner Hospital, Nedlands, Australia.
  • Sabesan S; Townsville Hospital, Townsville, Australia.
  • Shannon J; Nepean Cancer Care Centre, Kingswood, Australia.
  • Townsend A; Department of Hematology and Oncology, Queen Elizabeth Hospital, CALHN, Adelaide, South Australia.
  • O'Callaghan CJ; Canadian Cancer Trials Group, Queen's University, Kingston, ON.
  • Chen EX; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto ON. Electronic address: eric.chen@uhn.ca.
Clin Colorectal Cancer ; 22(4): 457-463, 2023 12.
Article en En | MEDLINE | ID: mdl-37704538
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_diarrhea Asunto principal: Neoplasias Colorrectales / Proteínas Proto-Oncogénicas p21(ras) Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Clin Colorectal Cancer Asunto de la revista: GASTROENTEROLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_diarrhea Asunto principal: Neoplasias Colorrectales / Proteínas Proto-Oncogénicas p21(ras) Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Clin Colorectal Cancer Asunto de la revista: GASTROENTEROLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article